Welcome to LookChem.com Sign In|Join Free

CAS

  • or

875558-38-6

Post Buying Request

875558-38-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

875558-38-6 Usage

General Description

Quinoxaline-6-carboxylic acid methoxy-methyl-amide, also known as Methyl 2-methoxy-N-(1-oxoquinoxalin-6-yl) acetimidate, is a chemical compound with the molecular formula C12H12N4O3. It is a derivative of quinoxaline, which is a heterocyclic compound containing a benzene ring fused to a pyrazine ring. Quinoxaline-6-carboxylic acid methoxy-methyl-amide is a white to off-white solid that is primarily used in pharmaceutical research and development. It has potential applications in the synthesis of various bioactive molecules and pharmaceutical compounds. Additionally, it may also have uses in other fields such as materials science and agrochemicals. Its chemical structure and properties make it a versatile and valuable building block for the creation of new chemical entities.

Check Digit Verification of cas no

The CAS Registry Mumber 875558-38-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,5,5 and 8 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 875558-38:
(8*8)+(7*7)+(6*5)+(5*5)+(4*5)+(3*8)+(2*3)+(1*8)=226
226 % 10 = 6
So 875558-38-6 is a valid CAS Registry Number.

875558-38-6Relevant articles and documents

ANTI-HCMV COMPOSITIONS AND METHODS

-

Page/Page column 25; 33; 35; 37, (2016/06/06)

Novel compounds useful for treating and/or preventing HCMV infections are provided.

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

-

Paragraph 0181, (2013/04/13)

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described. Specifically quinoxaline derivatives of Formula I and their use in modulating the activity of Braf and/or mutant Braf kinase to reg

Certain Chemical Entities, Compositions, and Methods

-

Paragraph 0453; 0454; 0455, (2013/03/26)

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of using these chemical entities, e.g., for treatment of cancer are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 875558-38-6